MKI67 and glioblastoma: In one of the glioblastoma cases of our initial cohort, we noted that HAVOC partitioning captured a BRAFV600E-mutated tumor subclone, showing an elevated Ki-67 (MIB1) proliferation index on immunohistochemistry (Fig. 2A).